Biltmore Family Office, LLC Pfizer Inc Transaction History

Biltmore Family Office, LLC

$678 Million
Q3 2025

A detailed history of Biltmore Family Office, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Biltmore Family Office, LLC holds 18,262 shares of PFE stock, worth $458,010. This represents 0.07% of its overall portfolio holdings.

Number of Shares

18,262

Previous 18,724 2.47%

Holding current value

$458,010

Previous $453,000 2.65%

% of portfolio

0.07%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$23.29 - $25.88 $10,759 - $11,956	-462 Reduced 2.47%	18,262 $465,000
Q2 2025 Aug 01, 2025	SELL	$21.59 - $24.84 $3,454 - $3,974	-160 Reduced 0.85%	18,724 $453,000
Q1 2025 May 12, 2025	BUY	$25.01 - $27.13 $8,828 - $9,576	353 Added 1.9%	18,884 $478,000
Q4 2024 Feb 12, 2025	SELL	$24.8 - $30.19 $2,827 - $3,441	-114 Reduced 0.61%	18,531 $491,000
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $28,946 - $32,802	1,045 Added 5.94%	18,645 $539,000

Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $3,961 - $4,548	153 Added 0.88%	17,600 $488,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $57,747 - $75,007	-2,210 Reduced 11.24%	17,447 $502,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $8,568 - $10,015	-267 Reduced 1.34%	19,657 $652,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $58,044 - $67,156	-1,607 Reduced 7.46%	19,924 $730,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $9,532 - $12,409	242 Added 1.14%	21,531 $878,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $11,063 - $14,442	265 Added 1.26%	21,289 $1.09 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $3,106 - $3,792	71 Added 0.34%	21,024 $920,000
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $33,501 - $39,722	-720 Reduced 3.32%	20,953 $1.1 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $34,312 - $42,517	-750 Reduced 3.34%	21,673 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $50,534 - $74,908	1,223 Added 5.77%	22,423 $1.32 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $70,650 - $90,756	-1,800 Reduced 7.83%	21,200 $912,000
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $21,366 - $24,204	-595 Reduced 2.52%	23,000 $901,000
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $63,764 - $71,914	-1,904 Reduced 7.47%	23,595 $855,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $123,069 - $156,493	3,677 Added 16.85%	25,499 $939,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $4,222 - $4,954	-133 Reduced 0.61%	21,822 $801,000
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $219,363 - $266,120	-7,283 Reduced 24.91%	21,955 $718,000
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $258,109 - $368,782	-9,549 Reduced 24.62%	29,238 $954,000
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $257,006 - $291,669	-7,807 Reduced 16.76%	38,787 $1.52 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $598,173 - $775,655	18,411 Added 65.33%	46,594 $1.67 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $100,178 - $112,477	-2,709 Reduced 8.77%	28,183 $1.22 Million
Q1 2019 Apr 12, 2019	SELL	$37.5 - $41.2 $33,675 - $36,997	-898 Reduced 2.82%	30,892 $1.31 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $24,313 - $27,719	632 Added 2.03%	31,790 $1.39 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $75,902 - $92,065	-2,202 Reduced 6.6%	31,158 $1.37 Million
Q2 2018 Jul 17, 2018	SELL	$32.98 - $35.16 $1.67 Million - $1.78 Million	-50,620 Reduced 60.28%	33,360 $1.21 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $77,062 - $89,403	-2,415 Reduced 2.8%	83,980 $2.98 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $2.87 Million - $3.05 Million	86,395	86,395 $3.13 Million

Others Institutions Holding PFE

# of Institutions

3,372

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Pfizer Inc Transaction History